Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
- PMID: 34201867
- PMCID: PMC8293038
- DOI: 10.3390/curroncol28040213
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Abstract
Background: Squamous cell carcinoma (SCC) is one of the most common cancers involving skin and oral mucosa. Although this condition's gold-standard treatment is the surgical removal of the lesions, the physician must propose alternative treatments in some cases due to the patient's ineligibility for surgery. Among the available alternative therapies, local chemotherapy may represent an initial treatment in combination with radiotherapy or systemic chemotherapy due to the low frequency of side-effects and the lack of necessity for expensive devices. Methods: In this paper, we review all available literature in various databases (PubMed, Scopus-Embase, Web of Science), proposing local chemotherapy as a treatment for cutaneous and oral SCC. Exclusion criteria included ocular lesions (where topical treatments are common), non-English language, and non-human studies. Results: We included 14 studies in this review. The majority were case reports and case series describing the treatment of non-resectable localized SCC with either imiquimod or 5-fluorouracil. We also analyzed small studies proposing combination treatments. Almost all studies reported an excellent clinical outcome, with a low risk of relapses in time. Conclusions: Resection of the lesion remains the gold-standard treatment for SCC. When this approach is not feasible, local chemotherapy may represent a treatment alternative, and it may also be associated with radiotherapy or systemic chemotherapy.
Keywords: 5-fluorouracil; imiquimod; squamous cell carcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.J Drugs Dermatol. 2021 Mar 1;20(3):260-267. doi: 10.36849/JDD.5427. J Drugs Dermatol. 2021. PMID: 33683072
-
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.Cutis. 2007 Mar;79(3):241-8. Cutis. 2007. PMID: 17674590
-
Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.Dermatol Surg. 2001 Jun;27(6):561-4. doi: 10.1046/j.1524-4725.2001.00149.x. Dermatol Surg. 2001. PMID: 11442593
-
Intralesional 5-fluorouracil as a management for cutaneous squamous cell carcinomas: A rural Australian retrospective case series.Australas J Dermatol. 2023 Nov;64(4):556-559. doi: 10.1111/ajd.14148. Epub 2023 Sep 4. Australas J Dermatol. 2023. PMID: 37665127 Review.
-
Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.J Drugs Dermatol. 2021 Feb 1;20(2):192-198. doi: 10.36849/JDD.5518. J Drugs Dermatol. 2021. PMID: 33538569
Cited by
-
SOD2 Enhancement by Long-Term Inhibition of the PI3K Pathway Confers Multi-Drug Resistance and Enhanced Tumor-Initiating Features in Head and Neck Cancer.Int J Mol Sci. 2021 Oct 19;22(20):11260. doi: 10.3390/ijms222011260. Int J Mol Sci. 2021. PMID: 34681918 Free PMC article.
-
CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer.Cancers (Basel). 2022 Jan 19;14(3):492. doi: 10.3390/cancers14030492. Cancers (Basel). 2022. PMID: 35158760 Free PMC article.
-
Recent Advances in Phenolic Metabolites and Skin Cancer.Int J Mol Sci. 2021 Sep 8;22(18):9707. doi: 10.3390/ijms22189707. Int J Mol Sci. 2021. PMID: 34575899 Free PMC article. Review.
-
Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC).Cancers (Basel). 2021 Nov 23;13(23):5890. doi: 10.3390/cancers13235890. Cancers (Basel). 2021. PMID: 34884998 Free PMC article.
-
Perception and Performance of Physical Activity Behavior after Head and Neck Cancer Treatment: Exploration and Integration of Qualitative and Quantitative Findings.Int J Environ Res Public Health. 2021 Dec 28;19(1):287. doi: 10.3390/ijerph19010287. Int J Environ Res Public Health. 2021. PMID: 35010547 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials